MCP
TNDM icon

Meridiem Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Meridiem Capital Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5M Buy
+298,255
New +$5.21M 0.2% 81

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Meridiem Capital Partners's TNDM Position: Q2 2026 in Review

Meridiem Capital Partners opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 298,255 shares worth $4.5M. The stake represents 0.2% of the portfolio and ranks #81 among its holdings.

274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Meridiem Capital Partners held 298,255 shares of Tandem Diabetes Care worth $4.5M as of Q2 2026.
  • Tandem Diabetes Care was a new Meridiem Capital Partners position in Q2 2026.
  • Tandem Diabetes Care made up 0.2% of Meridiem Capital Partners's portfolio in Q2 2026, its #81 holding.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.